.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A recent clinical study has uncovered that multiracial Asian and Pacific Islander (AAPI) populations face a uniquely high multiracial diabetic cardiovascular risk. While single-race Asian groups often show a lower cardiovascular disease burden than White populations, this biological advantage vanishes for those of multiracial heritage. Researchers analyzed electronic health record data from over 300,000 individuals in California and Hawaii. They found that diabetes drastically amplifies the risk of life-threatening events across all racial groups.
The data revealed striking disparities. People with diabetes had a nearly 4-fold greater incidence of myocardial infarction (MI) compared to those without the condition. Furthermore, stroke incidence was three times higher among diabetic patients. Surprisingly, specific multiracial combinations faced even higher rates than Non-Hispanic White individuals. For example, individuals identifying as Pacific Islander, Asian, and White showed an MI incidence of 16.6 per 1000 person-years. In contrast, Non-Hispanic White individuals with diabetes had an MI incidence of only 5.5.
Moreover, those with Pacific Islander and Asian ancestry recorded a stroke incidence of 11.1. These findings underscore the critical need for disaggregated data in clinical research. Physicians must recognize that the Asian category is not a monolith. Consequently, risk assessment tools should evolve to account for multiracial identities. Clinicians should prioritize aggressive management of risk factors in these vulnerable groups to mitigate future events.
Future studies are necessary to identify the specific social and genetic determinants driving this disproportionate burden. Social factors, such as discrimination or healthcare access, may play a significant role. Additionally, lifestyle variations within multiracial families could influence outcomes. Therefore, personalized care plans are essential for managing diabetes and cardiovascular health in multiracial patients.
The study found that multiracial AAPI individuals with diabetes have a significantly higher incidence of myocardial infarction and stroke compared to single-race Asian and White populations.
The research indicates that diabetes increases stroke incidence 3-fold across the studied groups, with multiracial individuals facing the highest overall rates.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Bacong AM et al. Increased Risk of Myocardial Infarction and Stroke Among Multiracial Asian and Pacific Islander Adults With Diabetes: Evidence From Electronic Health Records. J Am Heart Assoc. 2026 Apr 22. doi: 10.1161/JAHA.125.043657. PMID: 42017327.
Kwan TW et al. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2023 May 9. doi: 10.1161/CIR.0000000000001140.
American Heart Association. Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults. AHA News Release. 2025 March 6.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study highlights that multiracial Asian and Pacific Islander adults with diabetes face a higher risk of MI and stroke than their single-race counterparts....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
